Vaccine, cholera

Thông tin thuốc gốc
Chỉ định và Liều dùng
Active immunisation against cholera
Adult: As inactivated/killed vaccine: Primary immunisation: 2 doses at weekly interval. Complete course at least 14 days prior to exposure. Booster dose: As single dose within 2 years, if still at risk. As live attenuated vaccine: As single dose at least 10 days prior to potential exposure.
Child: As inactivated/killed vaccine: Primary immunisation: 2-6 years 3 doses at weekly interval. Complete course at least 14 days prior to exposure. Booster dose: As single dose within 6 months if still at risk. >6 years Same as adult dose.
Hướng dẫn pha thuốc
Lyophilised/Susp: Dissolve the buffer effervescent granules in at least 100-150 mL of purified water then add active component. Consume immediately after reconstitution.
Chống chỉ định
Thận trọng
Immunocompromised patients. Postpone immunisation in patients with acute gastrointestinal illness or acute febrile illness. Children. Pregnancy and lactation.
Phản ứng phụ
Significant: Shedding and transmission, altered immunocompetence.
Gastrointestinal disorders: Gastrointestinal discomfort, diarrhoea, abdominal pain, nausea, vomiting, abdominal cramps, acute gastroenteritis.
General disorders and administration site conditions: Fatigue, fever, weakness.
Nervous system disorders: Headache, dizziness.
Respiratory, thoracic and mediastinal disorders: Cough, rhinitis.
Skin and subcutaneous tissue disorders: Itching, rash.
Potentially Fatal: Hypersensitivity.
Tương tác
May diminish therapeutic effect with antibiotic and chloroquine. Reduced therapeutic effect with immunosuppressants.
Food Interaction
Impaired therapeutic effect with food and drinks.
Tác dụng
Description: Cholera vaccine contains either live attenuated or inactivated/killed strains of Vibrio cholerae bacteria. Live attenuated cholera vaccine replicates in the gastrointestinal tract causing immune response from the recipient thus increasing serum vibriocidal antibody within 10 days of vaccination, however, the exact immune mechanism is still unknown. Inactivated strains contain V. cholerae O1 and recombinant non-toxic B-subunit cholera toxin (CTB). It induces antibodies against both the bacterial component and CTB by preventing the bacteria from attaching to the intestinal wall thereby impeding colonisation of V. cholerae O1 and inhibiting the cholera toxin from binding to the intestinal mucosal surface hence, preventing toxin-mediated diarrhoeal symptoms.
Onset: Within 10 days.
Excretion: Via faeces.
Bảo quản
Lyophilised: Store between -25 to -15°C. Protect from light and moisture. Susp: Store between 2-8°C. Do not freeze.
Any unused portions or waste material should be disposed of in accordance with local requirements.
Phân loại ATC
J07AE02 - cholera, live attenuated ; Belongs to the class of cholera bacterial vaccines.
J07AE - Cholera vaccines ; Used for active immunizations.
J07AE01 - cholera, inactivated, whole cell ; Belongs to the class of cholera bacterial vaccines.
Anon. Cholera Vaccine Live Oral. AHFS Clinical Drug Information [online]. Bethesda, MD. American Society of Health-System Pharmacists, Inc. Accessed 03/08/2017.

Anon. Cholera Vaccine. Lexicomp Online. Hudson, Ohio. Wolters Kluwer Clinical Drug Information, Inc. Accessed 03/08/2017.

Buckingham R (ed). Cholera Vaccines. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. Accessed 03/08/2017.

Vaxchora (Paxvax, Inc.). DailyMed. Source: U.S. National Library of Medicine. Accessed 03/08/2017.

Thông báo miễn trừ trách nhiệm: Thông tin này được MIMS biên soạn một cách độc lập dựa trên thông tin của Vaccine, cholera từ nhiều nguồn tài liệu tham khảo và được cung cấp chỉ cho mục đích tham khảo. Việc sử dụng điều trị và thông tin kê toa có thể khác nhau giữa các quốc gia. Vui lòng tham khảo thông tin sản phẩm trong MIMS để biết thông tin kê toa cụ thể đã qua phê duyệt ở quốc gia đó. Mặc dù đã rất nỗ lực để đảm bảo nội dung được chính xác nhưng MIMS sẽ không chịu trách nhiệm hoặc nghĩa vụ pháp lý cho bất kỳ yêu cầu bồi thường hay thiệt hại nào phát sinh do việc sử dụng hoặc sử dụng sai các thông tin ở đây, về nội dung thông tin hoặc về sự thiếu sót thông tin, hoặc về thông tin khác. © 2021 MIMS. Bản quyền thuộc về MIMS. Phát triển bởi
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in